Truist Financial’s Repligen RGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$357K Sell
3,031
-641
-17% -$89.5K ﹤0.01% 2289
2025
Q4
$602K Buy
3,672
+1,237
+51% +$194K ﹤0.01% 1942
2025
Q3
$325K Sell
2,435
-717
-23% -$87.1K ﹤0.01% 2261
2025
Q2
$392K Sell
3,152
-691
-18% -$87.9K ﹤0.01% 2070
2025
Q1
$489K Buy
3,843
+890
+30% +$137K ﹤0.01% 1884
2024
Q4
$425K Sell
2,953
-378
-11% -$54.2K ﹤0.01% 1972
2024
Q3
$496K Buy
3,331
+664
+25% +$95.2K ﹤0.01% 1871
2024
Q2
$336K Sell
2,667
-680
-20% -$107K ﹤0.01% 2233
2024
Q1
$616K Sell
3,347
-903
-21% -$172K ﹤0.01% 1856
2023
Q4
$764K Buy
4,250
+538
+14% +$83.7K ﹤0.01% 1744
2023
Q3
$590K Buy
3,712
+300
+9% +$49K ﹤0.01% 1832
2023
Q2
$483K Buy
3,412
+576
+20% +$92.4K ﹤0.01% 1966
2023
Q1
$477K Sell
2,836
-1,997
-41% -$356K ﹤0.01% 2008
2022
Q4
$818K Sell
4,833
-362
-7% -$65.7K ﹤0.01% 1651
2022
Q3
$972K Sell
5,195
-171
-3% -$36.1K ﹤0.01% 1504
2022
Q2
$871K Sell
5,366
-256
-5% -$40.5K ﹤0.01% 1620
2022
Q1
$1.06M Sell
5,622
-1,256
-18% -$239K ﹤0.01% 1597
2021
Q4
$1.82M Sell
6,878
-469
-6% -$126K ﹤0.01% 1340
2021
Q3
$2.12M Buy
7,347
+1,336
+22% +$343K ﹤0.01% 1247
2021
Q2
$1.2M Buy
6,011
+567
+10% +$110K ﹤0.01% 1534
2021
Q1
$1.06M Buy
5,444
+152
+3% +$31.2K ﹤0.01% 1562
2020
Q4
$1.01M Buy
5,292
+722
+16% +$131K ﹤0.01% 1470
2020
Q3
$675K Sell
4,570
-315
-6% -$45K ﹤0.01% 1563
2020
Q2
$605K Sell
4,885
-769
-14% -$90.5K ﹤0.01% 1525
2020
Q1
$546K Sell
5,654
-285
-5% -$27.5K ﹤0.01% 1521
2019
Q4
$549K Buy
5,939
+1,098
+23% +$92.2K ﹤0.01% 1796
2019
Q3
$372K Sell
4,841
-1,564
-24% -$137K 0.01% 625
2019
Q2
$550K Sell
6,405
-255
-4% -$17.4K 0.01% 561
2019
Q1
$393K Buy
6,660
+75
+1% +$4.31K 0.01% 621
2018
Q4
$347K Sell
6,585
-585
-8% -$34.3K 0.01% 616
2018
Q3
$398K Sell
7,170
-415
-5% -$21.4K 0.01% 626
2018
Q2
$357K Sell
7,585
-380
-5% -$15.6K 0.01% 646
2018
Q1
$288K Buy
7,965
+120
+2% +$4.22K 0.01% 669
2017
Q4
$285K Sell
7,845
-30
-0.4% -$1.09K 0.01% 688
2017
Q3
$302K Sell
7,875
-185
-2% -$7.75K 0.01% 680
2017
Q2
$334K Sell
8,060
-90
-1% -$3.42K 0.01% 642
2017
Q1
$287K Sell
8,150
-415
-5% -$13.1K 0.01% 705
2016
Q4
$264K Sell
8,565
-70
-0.8% -$2.17K 0.01% 732
2016
Q3
$261K Sell
8,635
-180
-2% -$5.43K 0.01% 729
2016
Q2
$241K Buy
+8,815
New +$225K 0.01% 756

Other funds holding RGEN

Truist Financial's RGEN Position: Q1 2026 in Review

Truist Financial reduced its Repligen (RGEN) stake by 17% in Q1 2026, selling an estimated $89.5K and leaving 3,031 shares worth $357K. The position accounts for ﹤0.01% of the portfolio, ranked #2289.

Truist Financial first reported a position in RGEN in Q2 2016 and has held it in 40 quarters since. The position peaked at $2.12M in Q3 2021. 441 funds tracked by Wall St. Rank hold RGEN as of Q1 2026.

  • Truist Financial held 3,031 shares of Repligen worth $357K as of Q1 2026.
  • Truist Financial sold 641 Repligen shares in Q1 2026, an estimated $89.5K.
  • Repligen made up ﹤0.01% of Truist Financial's portfolio in Q1 2026, its #2289 holding.
  • Truist Financial first reported a position in Repligen in Q2 2016 and has held it in 40 quarters since.
  • Truist Financial's Repligen position peaked at $2.12M in Q3 2021.
  • 441 funds tracked by Wall St. Rank held Repligen as of Q1 2026.

Based on Truist Financial's 13F filing for Q1 2026, filed 27 Apr 2026.